Related Experiment Video
Updated: Jul 14, 2026
04:53
An In Vitro Approach to Photodynamic Therapy
Published on: August 17, 2018
8.6K
Resolution of Treatment-Refractory Papulopustular Rosacea With Combined Light Source Photodynamic Therapy Using
Merry A Mathew1, Kritin K Verma1, Daniel Friedmann2
1School of Medicine, Texas Tech University Health Sciences Center, Lubbock, USA.
Cureus
|December 27, 2024
Summary
Photodynamic therapy with aminolevulinic acid (ALA-PDT) combined with nonablative fractionated laser resurfacing (NAFR) effectively treated severe papulopustular rosacea. This approach offers a new option for patients resistant to standard therapies.
Area of Science:
- Dermatology
- Photomedicine
Background:
- Papulopustular rosacea is an inflammatory skin condition impacting quality of life.
- Current treatments include topical/oral medications and laser therapies.
Observation:
- Photodynamic therapy with aminolevulinic acid (ALA-PDT) is a newer treatment for rosacea.
- Nonablative fractionated laser resurfacing (NAFR) may improve ALA delivery.
- A case of 10-year treatment-refractory papulopustular rosacea is presented.
Findings:
- The patient's refractory papulopustular rosacea resolved with ALA-PDT using pre-incubation NAFR.
- This combination therapy demonstrated significant efficacy.
Implications:
- This case suggests ALA-PDT with NAFR is a viable alternative for severe, treatment-resistant rosacea.
- This novel approach may benefit patients unresponsive to conventional treatments.
